Atabak Mokari insider trades
Open-market stock purchases and sales by Atabak Mokari, Chief Financial Officer at Corcept Therapeutics Inc, from SEC Form 4 filings since Jul 27, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | CORT Corcept Therapeutics Inc | Sold (not open market) | $11.6K |
| Sep 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $15.6K |
| Sep 1, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $443K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $958K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $43.4K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $242K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $66.6K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $532K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $1.8M |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $1.6M |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $829K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $975K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $568K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $972K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Sold | $121K |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $1.8M |
| Jul 30, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Sold | $687K |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Sold | $2.5M |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Sold | $311K |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Sold | $9K |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $305K |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | $557K |
| Jul 15, 2026 | CORT Corcept Therapeutics Inc | Bought (not open market) | — |